Ropes & Gray advised Bain Capital Life Sciences on the final close of its fourth fund, Bain Capital Life Sciences Fund IV, with approximately $3 billion of total commitments. The fund close was announced in a press release on September 10.
The fund includes approximately $2.5 billion of outside commitments from existing and new investors, and will draw on Bain Capital Life Sciences multi-decade investment experience to invest scale capital globally in transformative medicines, medical devices, diagnostics, and life sciences tools that have the potential to improve the lives of patients with unmet medical needs.
The Ropes & Gray team included asset management partners Bryan Hunkele, Jon Rash, Eve Ellis and Peter Laybourn, and tax partner Jim Brown.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.